After two previous episodes, in 2002 and 2012, when two highly pathogenic coronaviruses (SARS, MERS) with a zoonotic origin emerged in humans and caused fatal respiratory illness, we are today experiencing the COVID-19 pandemic produced by SARS-CoV-2. The main question of the year 2021 is if naturally- or artificially-acquired active immunity will be effective against the evolving SARS-CoV-2 variants. This review starts with the presentation of the two compartments of antiviral immunity—humoral and cellular, innate and adaptive—underlining how the involved cellular and molecular actors are intrinsically connected in the development of the immune response in SARS-CoV-2 infection. Then, the SARS-CoV-2 immunopathology, as well as the derived diagnosis and therapeutic approaches, will be discussed.
【저자키워드】 antibodies, SARS-CoV-2, Inflammation, immune response, Lymphocytes, Antiviral, 【초록키워드】 coronavirus, Immunity, SARS-COV-2 infection, COVID-19 pandemic, Human, Diagnosis, Respiratory illness, immunopathology, MERS, SARS-CoV-2 variants, cellular, therapeutic approaches, zoonotic origin, highly pathogenic, effective, produced, caused, involved, question, cellular and molecular, intrinsically, the SARS-CoV-2, 【제목키워드】 response,